chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I suffered with severe tachycardia about 9 hrs after dose. Tachycardia lasted about 15 minutes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 21Sep2023 at 11:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history included: "CHF" (unspecified if ongoing); "HTN" (unspecified if ongoing); "macular degeneration" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN; METOPROLOL; HCTZ. Past drug history included: Augmentin, reaction(s): "Drug allergy: Augmentin". Vaccination history included: Covid-19 vaccine (Dose number: 3 Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose number: 2 Unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose number: 1 Unknown manufacturer), for Covid-19 immunization. The following information was reported: TACHYCARDIA (non-serious) with onset 21Sep2023 at 20:00, outcome "unknown", described as "I suffered with severe tachycardia about 9 hrs after dose. Tachycardia lasted about 15 minutes". Therapeutic measures were not taken as a result of tachycardia.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
7 days after receiving the shingrix injection pt developed symptoms of shingles (burning skin, eye pain), rash developed 2 days later and seen in clinic 2 days after rash started. Placed on valtrex and evaluated by ophthalmology, no conjunctival involvement was noted.  Symptoms improved but then recurred. Since then has suffered chronic pain and being treated for post-herpetic neuralgia as of 5/26/21.
Ten minutes after receiving first does of .5 ml covid vaccine IM vaccine in left deltoid, patient grabbed her throat and said "I am having trouble swallowing." Healthcare staff assessed airway and breathing and began monitoring vital signs. Airway was patent and breathing unlabored but rapid potentially due to anxiety.  B/P at on set was 174/88, heart rate 78 and O2 at 99% saturation.  Continued to monitor and between 3:28 and 3:29 pm patient begin to have visible difficulty shallowing and slight red rash began to appear on right forearm (note administration site was in left deltoid)  as a result of symptoms .5 epi was administered in outer lateral thigh IM. EMS called.  Blood pressure 178/85, heart rate 100,  Patient vital signs remained stable throughout and O2% remained at 98 to 99% Blood pressure remained around 170s/ 70s to 80s.  EMS at 3:42pm arrived and patient transferred without incident. Patient remained stable after first epi injection but did not improve.
Presented 3 days after immunization with localized pain, erythema, edema, at the injection site.
Patient received vaccine 3/25/21 and woke up 3/26/21 with the lymph node behind the ear and on the jaw swollen
Throwing up, Blurred vision, Passing out, Lack of Appetite, incoherent.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a elderly male patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of a SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported but the patient could be 72 or 73 years old. The patient received 1st dose of SHINGRIX on right arm and experienced flu like symptoms. The reporter had denied permission to contact their physician and could not provide any extra information. This case was linked with US2018056966, reported by the same reporter for same patient.
Patient was given the combo ProQuad which is only recommended for 2 years to 12 years. Parents were notified by the physician. No further action was required.
persistent nasty taste in my mouth; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 80 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 12Apr2021 (Lot number: ER8727, Expiration Date: 31Jul2021) at the age of 80 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TASTE DISORDER (non-serious) with onset 12Apr2021, outcome "unknown", described as "persistent nasty taste in my mouth".  No follow-up attempts are possible. No further information is expected.
bit nauseas; Not been feeling well; he still feel sick; Not been feeling well; he still feel sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 60 year-old male patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Lot number: ER8729, Expiration Date: 31Jul2021) at the age of 60 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Pain" (unspecified if ongoing), notes: He is on medications for pain and Prostrate. The patient's concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 15Apr2021, outcome "unknown", described as "bit nauseas"; ILLNESS (non-serious), MALAISE (non-serious) all with onset 15Apr2021, outcome "unknown" and all described as "Not been feeling well; he still feel sick". Therapeutic measures were taken as a result of nausea, illness, malaise.  Additional Information: The consumer (Patient's wife) reported that, He was on medications for pain and Prostrate. Me and my husband had the shot on 15th and my husband since 15th he's not been feeling well and my question is everything, I read about taking the shot says 2-3 days like, 24-48 hours, a few days but now we're at a week later and he still feel sick. Reporter stated, "We both got but I already said I didn't get sick and he has not felt well since then, the first day he came out with felling a bit nauseas, you know nausea and then he had a lot of issues and I am not sure what is going on here." Reporter stated, "I just want to know if this is normal or not." Treatment was given with, "Compazine." Reporter seriousness for the events were unspecified.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Received call from patients mother who stated that child's left deltoid where DTAP-IPV was given was extremely red and swollen, mother directed to contact her child's pediatrician and to monitor the site and if child has any breathing issues to take her to ER right away. Mother stated that if she called pediatrician but they can not see her until next week, mother then was urged to take child to urgent care to be seen she v/u.
PATIENT REFERS 3 DAYS AFTER VACCINATION BEGAN HAVING CRAMPS IN THE LEFT ARM (WHERE SHE WAS VACCINATED). REFERS SHE STILL ARE EXPERIENCING THEM.
body aches, headache, chills, slight fever (100.5), nausea, vomiting. No treatment. Rested and stayed hydrated. Nausea lasted 24 hours. Rest of the symptoms lasted approximately 36 hours.  Tiredness, short of breath - lasted for about 60 hours after injection.
Patient arm was swollen for 2 days , had radishes around the shot and was very sore
On Day 4: Swollen lips; canker-like sore on lower lip, upper gum; Day 5: Swollen lips, Swollen tongue with increase in canker-like lesions.
Rash appearing 9/2/02, rhinorrhea, malaise. Rash covered trunk, face, limbs-pruritic. Tx with Benadryl, OTC analgesia.
This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 87-year-old female patient who received SHINGRIX for prophylaxis. On 5th June 2018, the patient received the 1st dose of SHINGRIX. On 6th June 2018, 1 days after receiving SHINGRIX, the patient experienced tiredness and itchy rash. In June 2018, the patient experienced injection site pain, lower extremities weakness of and dizziness. On 7th June 2018, the outcome of the itchy rash was recovered/resolved. On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the lower extremities weakness of, dizziness and tiredness were unknown. It was unknown if the reporter considered the injection site pain, lower extremities weakness of, dizziness, tiredness and itchy rash to be related to SHINGRIX. Additional details were provided as follows: The patient receive SHINGRIX in left arm. Less than a week after receiving SHINGRIX, the patient experienced injection site pain which had since resolved. The patient later developed progressive leg weakness, dizziness. The healthcare professional reported that, the patient felt tired and developed an itchy rash on their right forearm, wrist and hand area. Initially spoke to office secretary, who then passed the phone to the physician. The physician did not want to share further information. The office secretary stated that, the vaccine was administered at another facility.
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Bloom consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the DPHE on a compliance improvement plan and has been reinstated vaccination privileges.
Beyond Horrible Fatigue, Could not wallk without falling over, sever cold sweats, severe headaches
Redness, itching, swelling, hard lump and hot to touch around injection site 8 days after vaccine was administered. Swelling/hard lump grew twice in size in 48 hours. PCP stated this is probably an delayed localized immune reaction of hives.
06JUL2017 - Vaccination at 8:30am. 08JUL2017 - Spiked mild fever at 11:30am (100.9 degrees). Fever continued on/off through 11JUL2017. 08JUL2017-09JUL2017 - Given TYLENOL for fever. Took an hour for fever to subside and broke through again an hour after that. 10JUL2017 - Began giving MOTRIN for fever. Fever subsided within 20 minutes. 11JUL2017 - Rash on  neck/chest. Rash continued to spread to back, ears, and below waist. Still spreading today 13JUL2017. The bumps are raised, turn white when pressure applied. 11JUL2017 - Woke up at 10pm screaming and arching back. Was consolable only for 5-10 minutes at a time. Continued until 11:30pm. 12JUL2017 - Morning screaming and arching back. Extreme fussiness all day. 13JUL2017 - Rash has spread to face.
Reports to ED day after 2nd covid vaccine with chest pain. EKG and trop normal.
Chills; Hot; Cold; sweats-very wet arms/chest; Terrible headache; joint and muscle aches; Fatigue; Feels weak; extreme nausea; sick-rally bad-had all the symptoms for 3 days; dose really high up on the shoulder and it hurt; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick-rally bad-had all the symptoms for 3 days), PAIN IN EXTREMITY (dose really high up on the shoulder and it hurt), CHILLS (Chills), FEELING HOT (Hot) and NASOPHARYNGITIS (Cold) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (dose really high up on the shoulder and it hurt). On 03-Apr-2021, the patient experienced ILLNESS (sick-rally bad-had all the symptoms for 3 days), CHILLS (Chills), FEELING HOT (Hot), NASOPHARYNGITIS (Cold), HYPERHIDROSIS (sweats-very wet arms/chest), HEADACHE (Terrible headache), ARTHRALGIA (joint and muscle aches), FATIGUE (Fatigue), ASTHENIA (Feels weak) and NAUSEA (extreme nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ILLNESS (sick-rally bad-had all the symptoms for 3 days), PAIN IN EXTREMITY (dose really high up on the shoulder and it hurt), CHILLS (Chills), FEELING HOT (Hot), NASOPHARYNGITIS (Cold), HYPERHIDROSIS (sweats-very wet arms/chest), HEADACHE (Terrible headache), ARTHRALGIA (joint and muscle aches), FATIGUE (Fatigue), ASTHENIA (Feels weak) and NAUSEA (extreme nausea) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
About 12 hours after the shot, I began to experience a low-grade fever. The fever never exceeded 100 degrees and lasted about 24 hours. I had difficulty sleeping throughout the night. The next day, I had a splitting headache the next day and arm pain. I was mildly nauseous. The worst was intermittent rapid heart rate.  I wear a FitBit and my heart would race for 2-3 minutes at a time, topping 130 beats per minute, while I was sitting on the couch doing nothing.
Following 3rd dose of vax w/in 90 sec pt had onset of dizziness (still present) & w/in 3 min she experienced severe h/a also shoulder pain; Impression: Labyrinthitis, poss secondary to Hep B vax; Went to ER; felt poss pass out;
Hospitalized 5/2/21 for chest pain. Diagnosis of Pericarditis, Thought to be cocaine induced . Diagnosed with NSTEMI. New medication in discharge. Aspirin 81 mg, atorvastatin .40mg, colchicine 0.8 mg.  Presented to ED 5/2/21 with chest pain radiating down left arm onset AM of 5/2/21, pressure like in nature. 4/10 severity. 5/1/21 evening drink large amount of alcohol and cocaine. COVID vaccine #2 on 4/27/21
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 31-Aug-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Date of refrigeration is given as 7-May-2021. No concomitant and treatment medications are provided by the reporter.
It was started with Itchiness, red rashes. It felt like burning and itchy all over the body from head to toes. Initial two days took OTC allergy tablets and vaseline, That was not effective. So called to telemedicine . Doctor prescribed Cetirizine 10mg tablet and Triamcinolone 0.1% cream for a month.
Redness and swelling right arm from elbow to shoulder area. Painful to touch. To ER at 9:30pm 10/30/2002. No Tx. To MD 10/31/2002. Diphenhydramine prescribed. Allergic reaction diagnosed. 11/04/2002 phone call from client. He cancelled flu appt for  Seen by MD 11/01/2002- today 11/04/2002. He stated mu arm is better today, no swelling or pain.
Pt recvd vax on 06DEC72; On 25JUL90 recvd booster does of MMR; On 04AUG90 pt devel fever that was assoc w/generalized aching, t104; 05AUG90 devel morbilliform pruritic rash considered to be typical of measles; postauricular nodes were noted
Myalgia, Fatigue Narrative: Missed work following second dose due to above symptoms
Immediately after administered booster dose my blood pressure dropped, manifesting in lightheadedness, weakness/tingly feeling in hands and feet, and sudden sleepiness. That lasted for the entire afternoon, extreme sleepiness and tiredness. I took 800mg paracetamol at night. The next day, morning chills 99F and a large lump in my vaccinated arm armpit, size of a very large egg. Not painful to the touch, just protruding above normal body contour.
Currently both arms go numb; fall asleep while I am sleeping; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 22Dec2020 (Lot number: EK5730, Expiration Date: 31Mar2021) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "Currently both arms go numb"; SOMNOLENCE (non-serious), outcome "unknown", described as "fall asleep while I am sleeping".  Additional information: Patient Prior Vaccination (within 4 weeks) was none. Patient concomitant drugs was none. Patient medical history was none. Patient relevant tests was none. Patient started Tylenol on 09Jan2021. Currently both patient arms go numb- fall asleep while patient was sleeping. This happens intermittently. Patient have never experienced the Frequency of both arms going numb before the vaccine.  Follow-up attempts are completed. No further information is expected.
cancer; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Lot number and expiration date was not reported) as unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient acquired cancer after receiving the vaccine on an unspecified date. The outcome of the event was unknown.  Information on the batch/lot number has been requested.
Patient was vaccinated with FLUZONE QUAD and had no symptoms/signs of reaction at time or immediately after injection. Approximately 7 to 10 minutes after injection, the patient had fainted before leaving the store. She was dazed, confused, and flush. She was conscious on the floor for 15 minutes while paramedics arrived. Vitals were normal. Blood glucose readings were a little low. On follow-up, patient has had no further symptoms.
Swelling of L thigh. Red and swollen 10 X 11cm size.
Patient had onset of blistering to ears, armpits, back of legs and groin.  Patient decided to not get 2nd dose after reaction to 1st dose.
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided. No treatment information was provided.  Patient did not had any adverse event.
Numbness of extremities, jaw and drooping of left eyelid gradually occurring 3 wks after 2nd anthrax vaccine. Poor balance-unable to walk without assistance, with gradual improvement. Lingering pain in arms and feet.
Severe body aches from neck, shoulders, back, legs, took ibuprofen with no results.
Pt complained of severe (R) arm pain & swelling at injection site, no fever or chills, no redness to site on exam firm & swollen (R) deltoid - pt sent home to use NSAIDS & ice.
Shingles; This is a spontaneous report from a contactable consumer (patient) reported that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 15Mar2021 as 1st dose, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had his/her Pfizer Vaccine on 15Mar2021, and he/she was currently have shingles on Mar2021, and he/she was due to get the second one in a week. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
June 5th got very swollen could not go see a doctor till Monday got a ultrasound that morning to find out he has a blood clot. the leg is still very swollen and has to wear compression socks. After the 7th started to feel bad thought it was allergies got home June 18th and still wasn't feeling good so went and got a Covid test and it was positive.
Trouble breathing; nausea; severe headache/excruciating headache; Feeling generally unwell to the point I almost went to the emergency room/terribly unwell feeling; This is a spontaneous report from a contactable consumer (patient). A 72-years-old non-preganant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot EN5318, via an unspecified route of administration on 02Feb2021 15:45 (at the age of 72 years old) for COVID-19 vaccination, Unspecified other vaccine (Pfizer) on 02Feb2021, dose number in the left arm for an unspecified indication.Medical history included asthma from an unknown date and unknown if ongoing (asthma under control), pancreatitis chronic from an unknown date and unknown if ongoing (Occasional chronic pancreatitis), Blood pressure from an unknown date and unknown if ongoing, drug allergies from an unknown date and unknown if ongoing.  Concomitant medication included Blood pressure medication. The patient previously took morphine and experienced allergies morphine and sulfa and experienced allergies sulfa. The patient received the vaccination at the hospital. On 02Feb2021, the patient felt as if she was having a heart attack. On 02Feb2021, the patient had trouble breathing, nausea, and severe headache. On 02Feb2021, the patient was felling generally unwell to the point she almost went to the emergency room. The excruciating headache and terribly unwell feeling has lasted well over 10 days. No treatment was received for the events. Outcome of the events was recovering. The patient did not have covid prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19.
Could not walk without severe pain the night after thr injection.  Fever, chills, severe muscle and joint ach, cough, nasal and chest congestion, blisters on tongue and down throat,  severe laryngitis,  chest pain, headache,  blurred vision and elevated glucose.